Anti-Oxidative Potential of Biofield Energy Treatment on Lung Health Using A549 Cells

Journal: Advances in Pharmacology and Clinical Trials PDF  

Published: December 10, 2018 Volume: 3 Issue: 5 Pages: 1- 7

DOI: 10.23880/apct-16000145 ISSN: 2474-9214

Authors: Alice Branton and Snehasis Jana

Citation: Alice Branton. Anti-Oxidative Potential of Biofield Energy Treatment on Lung Health Using A549 Cells. Adv Pharmacol Clin Trials 2018, 3(5): 000145.

  • 45 Views
  • 1 Downloads

Abstract

Oxidative stress plays a crucial role in most of the diseases and their complications. The present investigation was undertaken to evaluate the anti-oxidative potential of Consciousness Energy Healing Treated DMEM medium on the level of protection against oxidative stress and superoxide dismutase (SOD) enzyme activity using A549 cells. The test item (DMEM) was divided into two parts. One portion was denoted as the untreated DMEM without any Biofield Energy Treatment, while the other portion was defined as the Biofield Energy Treated DMEM, which received the Biofield Energy Healing Treatment by a renowned Biofield Energy Healer, Alice Branton. The cell viability of the test items using MTT assay showed an increase viable cells by 122.60% in the Biofield Energy Treated DMEM, suggesting a safe and nontoxic profile of the test items. Furthermore, the cellular protection against oxidative stress was significantly increased by 60.50% in the Biofield Energy Treated DMEM group compared with the untreated DMEM group. Additionally, the SOD enzyme activity was significantly increased by 38.08% in the Biofield Energy Treated DMEM group compared with the untreated DMEM group. Thus, the overall in vitro lung health data suggest that the Consciousness Energy Healing Treatment showed a significant improvement of anti-oxidative potential against oxidative damage caused by free radicals and stress in A549 cells. It is concluded that the Biofield Energy Healing Treatment has the significant capacity to increase the SOD enzyme level (antioxidant activity) along with an improved cellular protection against oxidative damage. Thus, The Trivedi Effect® can be used in various human lung disorders such as asthma, chronic obstructive pulmonary disease (COPD), lung malignancies and parenchymal lung diseases like idiopathic pulmonary fibrosis and lung granulomatous diseases.

Conclusion

The cell viability using MTT assay showed 122.60% viable cells in the Biofield Treated DMEM group, suggesting a safe and nontoxic nature of the test item. Further, the cellular protection level against oxidative stress and the level of antioxidant enzyme SOD were significantly increased by 60.50% and 38.08% respectively, in the Biofield Energy Treated DMEM group compared with the untreated DMEM group. Thus, the result suggests that the Biofield Energy Treated (The Trivedi Effect®) DMEM showed a significant impact to protect from oxidative damage of human lung adenocarcinoma cells (A549). It can also be utilized for the management of various human lung disorders such as Asbestosis, Bronchiectasis, Bronchitis, Chronic Cough, Chronic Obstructive Pulmonary Disease (COPD), Common Cold, Cystic Fibrosis, Hantavirus, Idiopathic Pulmonary Fibrosis, Influenza, Lung Cancer, Pandemic Flu, Pertussis, Pleurisy, Pneumonia, Pulmonary Embolism, Respiratory Syncytial Virus (RSV), Sarcoidosis, Sleep Apnea, Sudden Infant Death Syndrome (SIDS), Tuberculosis, and WorkRelated Asthma. Besides, it may also control the immune related disease conditions such as Hashimoto Thyroiditis, Aplastic Anemia, Hepatitis, Diverticulitis, Pernicious Anemia, Sjogren Syndrome, Myasthenia Gravis, Parkinson’s Disease, Asthma, Graves’ Disease, Dermatomyositis, Multiple Sclerosis, Ulcerative Colitis, Alzheimer’s Disease, Dermatitis, Irritable Bowel Syndrome, Diabetes, Atherosclerosis, Systemic Lupus Erythematosus, stress, etc. with a safe therapeutic index to improve overall health, and Quality of Life.